Revvity Signals to Host NEXUS India 2024 User Conference to Drive Knowledge Sharing and Innovation aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.
Today, Revvity, Inc. announced that its software and informatics division, Revvity Signals, is unveiling the Signals Clinical™ solution, a software-as-a-service (SaaS), end-to-end clinical data science platform designed to centralize all clinical trial data, providing fast, actionable insights for quicker clinical decisions and accelerated market delivery of therapeutics.
- Centralized data science platform streamlines clinical study data management for swift, insight-driven clinical decisions and therapeutic advancements- Seamless integration with Spotfire® for powerful visual analytics enabling flexibility, easy customization and scalability- Fosters cross-functional collaboration.
PerkinElmer announced it will acquire Covaris, a manufacturer of applications and reagents used in life science research, as part of its goal to expand its life sciences portfolio.
As it relates to the existing brand architecture, Revvity said its BioLegend, Euroimmun, Tulip Diagnostics and ViaCord franchises will retain their respective names as unique product lines.